[Hemostasis in patients with diseases of the retina and uveal tract].
Hemostasis studies of 152 patients with inflammatory dystrophic and circulatory diseases of the retina and the uveal tract have shown that the major hemostasis disorders consisted in the presence of soluble fibrin monomer complexes in the blood of 62-90.5% of patients and in retarded lysis of the blood euglobulin fraction. Patients with the above hemostasis disorders and central serous chorioretinopathies and abiotrophies develop delayed formation of the fibrin clot and its poor retraction, that is characteristic of latent imbalance of the coagulation and fibrinolysis processes and liability to DIC. Patients with retinal vein thrombosis develop, besides delayed fibrin polymerization in the clot and reduction of platelet contractility, a drastic depression of the blood and lacrimal fibrinolytic activity. Central choroiditis and uveitis was associated with a marked increase of lacrimal fibrinolysis and reduced blood plasma fibrinolysis, along with enhanced paracoagulation and prolonged lysis of the blood euglobulin fraction, this resulting in hypoproteolytic hypercoagulation. Local and systemic fibrinolysis test may help choose the drugs for local and general pathogenetic therapy.
Pimenov
I V
IV
Zaĭtseva
N S
NS
Volkolakova
R Iu
RIu
D000293:Adolescent; D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D002833:Choroiditis / Q000097:blood; D006487:Hemostasis; D006801:Humans; D008875:Middle Aged; D012164:Retinal Diseases / Q000097:blood*; D012170:Retinal Vein Occlusion / Q000097:blood; D014603:Uveal Diseases / Q000097:blood*; D014605:Uveitis / Q000097:blood
Sostoianie gemostaza u bol'nykh s patologieĭ setchatki i sosudistogo trakta glaza.